The companies we spend time on are usually seed, early, or early-growth. They sit in advertising technology, financial technology, health, or financial services. They will need more than one decision about capital: a first financing, a later round, sometimes debt, sometimes a buyer or a merger.
That is the profile we bring to investors who would rather know the company than rent a place in a syndicate. Introductions are selective. We do not run a public deal feed, and this page is not an offer of any security.
Individual experience described on the team page is personal history. It is not a fund track record and should not be read as one.
Tell us who you represent and what you are prepared to look at. A member of the team will follow up if there is a reason to talk
Advertising and marketing technology. Software and platforms that help advertisers reach people, measure what happened, and run the work of marketing with less waste.
Financial technology. Software and platforms that change how money, credit, payments, risk, or financial operations actually move.
Health and life sciences technology. Devices, software, and solutions used by clinicians, operators, or patients — where the buyer is identifiable and the path to use is real.
Companies in financial services themselves, not only the software around them. We look for a clear customer, a compliance posture that can survive growth, and a reason the firm should exist beside incumbents.
Pharmaceuticals, biotechnology, medical devices, and other health-product innovation. This is a part of the practice with a long personal history on the team, including company-building, product acquisitions, and financing.